Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03356275 · ClinicalTrials.gov registry record · NA

Mobile Coach for Parents of Children and Adolescents With Chronic Pain

A NA study of Chronic Pain and Parents, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT03356275: Completed NA study of Chronic Pain and Parents, sponsored by University of California, Los Angeles.

NCT03356275 is a NA study of Chronic Pain and Parents that has completed, run by University of California, Los Angeles. The registered enrollment target is 34 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03356275, a NA study of Chronic Pain and Parents, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

Chronic pain is estimated to affect 20% to 35% of children and adolescents around the world, and is associated with increased risk of anxiety and depression among children and adolescents, as well as coping challenges, anxiety, depression, and anger in their parents. For parents, learning to manage stress is critical, as parents play a significant role in a child's experience of pain. Parental behaviors such as over-involvement, solicitousness and rejection are associated with decreased functioning, including higher school absenteeism in children and teens. A number of interventions demonstrate that teaching skills to parents can have a direct and positive impact on the health of children and adolescents with chronic pain. The investigators propose to create and test the BodiMojo Parent Buddy which will provide parents with real-time, tailored and adaptive coping and stress management support and will provide a curriculum of skills for responding to a child in pain in order to promote child functioning. Thirty parents of children ages 8-18 who have been diagnosed with a non-cancer chronic pain condition will participate in this user-testing study. Parents will complete a brief set of questionnaires before and after the intervention, and will be instructed to open and use the app each day for 30 days. Participants will complete audio mindfulness exercises, watch brief video clips, and read psychoeducational information about pain, coping, and communication skills. Post-intervention questionnaires will also include an acceptance test to assess participants' opinions about the helpfulness and usability of the app. Parent participation is expected to take around 3.5 hours total over the 30 day study period.

Primary Outcome

Determined by how often participants engaged and used certain features. To be considered feasible, participants must have opened the app on at least half of the days.

Interventions

  • BEHAVIORAL Mindfulness for Resilience in Illness: Support for Parents

Study Locations (1)

California

  • UCLA Pediatric Pain and Palliative Care Program Research Offices - Los Angeles

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-12-18
Est. Completion 2018-03-13
Phase NA

What the finished NCT03356275 record still lists

NCT03356275 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness for Resilience in Illness: Support for Parents is the first listed.

NCT03356275 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03356275 about?

NCT03356275 is a clinical study titled "Mobile Coach for Parents of Children and Adolescents With Chronic Pain". Chronic pain is estimated to affect 20% to 35% of children and adolescents around the world, and is associated with increased risk of anxiety and depression among children and adolescents, as well as coping challenges, anxiety, depression, and anger in their parents. For parents, learning to manage ...

What is the current status of trial NCT03356275?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2017-12-18. Estimated completion is 2018-03-13.

What conditions does trial NCT03356275 study?

This clinical trial studies the following conditions: Chronic Pain, Parents, Pediatric Disorder.

What interventions are being tested in trial NCT03356275?

The interventions under investigation include: Mindfulness for Resilience in Illness: Support for Parents (BEHAVIORAL).

Who is sponsoring clinical trial NCT03356275?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03356275 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03356275's enrollment target sits among peer trials

34 235th of 301 higher than 63 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03356275, the US trial registry maintained by the National Library of Medicine. NCT03356275 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.